Thermo Fisher Scientific reports Q2 non-GAAP EPS of $6.03 and revenue growth of 10.4% year-over-year.
Thermo Fisher Scientific posted second-quarter non-GAAP earnings per share of $6.03, exceeding estimates by $0.32. Revenue reached $11.99 billion, up 10.4% from the same period last year and $290 million above expectations.
The company’s revenue grew from $10.85 billion in Q2 2025, driven by organic sales. The results reflect continued demand across its scientific instruments and laboratory services segments.
Shares showed muted reaction in after-hours trading as investors digested the beat.